Inactive Instrument

Highlights Vynleads, Inc. Other OTC

Equities

VYND

US92940G1040

Highlights

Unlock all the news: Be the first to know and act before the market!

Vynleads, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Vynleads, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-22	CI
WG Capital, Ltd acquired 10.8% stake in Vynleads, Inc. from Sergei Stetsenko for $0.01 million.	03-19	CI
Vynleads, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Vynleads, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Vynleads, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Vynleads, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
Vynleads, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Vynleads, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-24	CI
Vynleads, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Vynleads, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22	CI
Vynleads, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-10-08	CI
Vynleads, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-06-29	CI
Vynleads, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-07	CI
Vynleads, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-19	CI
Sergei Stetsenko, Director, acquired an additional 10.8% stake in Vynleads, Inc. from Stanislav Bezusov, Chief Technology Officer and Director, for $0.01 million.	20-09-14	CI
Vynleads, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-14	CI
Vynleads, Inc.'s Dwd Protocol & Targeted Nutraceuticals Can Support Type-2 Diabetics Amidst Health Uncertainty	20-07-06	CI
Vynleads, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-29	CI
Vynleads, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-06-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Vynleads, Inc. Other OTC

Equities

VYND

US92940G1040

Highlights

Filters